(Q43937971)

English

Echogenicity of liver metastases from colorectal carcinoma is an independent prognostic factor in patients treated with regional chemotherapy

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Echogenicity of liver metastases from colorectal carcinoma is an independent prognostic factor in patients treated with regional chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Thomas Gruenberger

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Jing Zhao

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Julie King

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

TengTeng Chung

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Phil R Clingan

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

David L Morris

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

94

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1753-1759

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Resection of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Pharmacologic rationale for regional drug delivery.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

The natural history of primary and secondary malignant tumors of the liver I.The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Natural history of patients with untreated liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Multiple bilobar liver metastases: cryotherapy for residual lesions after liver resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Echogenicity of liver metastases is an independent prognostic factor after potentially curative treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Regional chemotherapy of colorectal cancer metastatic to the liver

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Pretreatment echogenicity of colorectal liver metastases predicts survival after hepatic cryotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10386

21 January 2018

Identifiers

10.1002/CNCR.10386

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43937971&oldid=2104516895"